{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:35:55Z","timestamp":1791995755203,"version":"4.4.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Open access funding enabled and organized by CAUL and its Member Institutions"},{"DOI":"10.13039\/501100001803","name":"Charles Darwin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001803","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40272-024-00680-4","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T04:45:13Z","timestamp":1737607513000},"page":"261-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Antibiotics for Paediatric Community-Acquired Pneumonia: What is the Optimal Course Duration?"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9781-5905","authenticated-orcid":false,"given":"Hing Cheong","family":"Kok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Moy","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle B.","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T.","family":"Yerkovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Grimwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"2","key":"680_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/s2352-4642(21)00311-4","volume":"6","author":"J Perin","year":"2022","unstructured":"Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000\u201319: an updated systematic analysis with implications for the sustainable development goals. Lancet Child Adolesc Health. 2022;6(2):106\u201315. https:\/\/doi.org\/10.1016\/s2352-4642(21)00311-4.","journal-title":"Lancet Child Adolesc Health"},{"key":"680_CR2","doi-asserted-by":"publisher","unstructured":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Infect Dis. 2024;24(9):974\u20131002. https:\/\/doi.org\/10.1016\/s1473-3099(24)00176-2.","DOI":"10.1016\/s1473-3099(24)00176-2"},{"key":"680_CR3","unstructured":"World Health Organization and United Nations International Children\u2019s Emergency Fund. Ending preventable child deaths from pneumonia and diarrhoea by 2025: the integrated global action plan for pneumonia and diarrhoea (GAPPD) 2013. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/79207\/WHO_FWC_MCA_13_01_eng.pdf. Accessed 21 October 2024."},{"issue":"1","key":"680_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.idc.2017.11.002","volume":"32","author":"SE Katz","year":"2018","unstructured":"Katz SE, Williams DJ. Pediatric community-acquired pneumonia in the United States: changing epidemiology, diagnostic and therapeutic challenges, and areas for future research. Infect Dis Clin North Am. 2018;32(1):47\u201363. https:\/\/doi.org\/10.1016\/j.idc.2017.11.002.","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"680_CR5","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1097\/INF.0b013e3182784b26","volume":"32","author":"SA Madhi","year":"2013","unstructured":"Madhi SA, De Wals P, Grijalva CG, Grimwood K, Grossman R, Ishiwada N, et al. The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J. 2013;32(3):e119\u201327. https:\/\/doi.org\/10.1097\/INF.0b013e3182784b26.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"680_CR6","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1542\/peds.2010-2008","volume":"127","author":"MP Kronman","year":"2011","unstructured":"Kronman MP, Hersh AL, Feng R, Huang YS, Lee GE, Shah SS. Ambulatory visit rates and antibiotic prescribing for children with pneumonia, 1994\u20132007. Pediatrics. 2011;127(3):411\u20138. https:\/\/doi.org\/10.1542\/peds.2010-2008.","journal-title":"Pediatrics"},{"issue":"8","key":"680_CR7","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/resp.13131","volume":"22","author":"TL Basnayake","year":"2017","unstructured":"Basnayake TL, Morgan LC, Chang AB. The global burden of respiratory infections in indigenous children and adults: a review. Respirology. 2017;22(8):1518\u201328. https:\/\/doi.org\/10.1111\/resp.13131.","journal-title":"Respirology"},{"issue":"7","key":"680_CR8","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/s2213-2600(24)00008-0","volume":"12","author":"AB Chang","year":"2024","unstructured":"Chang AB, Kovesi T, Redding GJ, Wong C, Alvarez GG, Nantanda R, et al. Chronic respiratory disease in Indigenous peoples: a framework to address inequity and strengthen respiratory health and health care globally. Lancet Respir Med. 2024;12(7):556\u201374. https:\/\/doi.org\/10.1016\/s2213-2600(24)00008-0.","journal-title":"Lancet Respir Med"},{"issue":"7","key":"680_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S2213-2600(18)30100-0","volume":"6","author":"DS Bui","year":"2018","unstructured":"Bui DS, Lodge CJ, Burgess JA, Lowe AJ, Perret J, Bui MQ, et al. Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life. Lancet Respir Med. 2018;6(7):535\u201344. https:\/\/doi.org\/10.1016\/S2213-2600(18)30100-0.","journal-title":"Lancet Respir Med"},{"key":"680_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10245727","author":"AJ Collaro","year":"2021","unstructured":"Collaro AJ, Chang AB, Marchant JM, Chatfield MD, Vicendese D, Blake TL, et al. Early childhood pneumonia is associated with reduced lung function and asthma in first nations Australian children and young adults. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10245727.","journal-title":"J Clin Med"},{"issue":"6","key":"680_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S2352-4642(23)00030-5","volume":"7","author":"AJ Collaro","year":"2023","unstructured":"Collaro AJ, McElrea MS, Marchant JM, Chatfield MD, Sondergeld P, Perret JL, et al. The effect of early childhood respiratory infections and pneumonia on lifelong lung function: a systematic review. Lancet Child Adolesc Health. 2023;7(6):429\u201340. https:\/\/doi.org\/10.1016\/S2352-4642(23)00030-5.","journal-title":"Lancet Child Adolesc Health"},{"issue":"10","key":"680_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/01.inf.0000142508.33623.2f","volume":"23","author":"PC Valery","year":"2004","unstructured":"Valery PC, Torzillo PJ, Mulholland K, Boyce NC, Purdie DM, Chang AB. Hospital-based case\u2013control study of bronchiectasis in indigenous children in Central Australia. Pediatr Infect Dis J. 2004;23(10):902\u20138. https:\/\/doi.org\/10.1097\/01.inf.0000142508.33623.2f.","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"680_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ppul.22763","volume":"49","author":"RJ Singleton","year":"2014","unstructured":"Singleton RJ, Valery PC, Morris P, Byrnes CA, Grimwood K, Redding G, et al. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease\/bronchiectasis. Pediatr Pulmonol. 2014;49(2):189\u2013200. https:\/\/doi.org\/10.1002\/ppul.22763.","journal-title":"Pediatr Pulmonol"},{"issue":"10383","key":"680_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(23)00131-9","volume":"401","author":"JP Allinson","year":"2023","unstructured":"Allinson JP, Chaturvedi N, Wong A, Shah I, Donaldson GC, Wedzicha JA, et al. Early childhood lower respiratory tract infection and premature adult death from respiratory disease in Great Britain: a national birth cohort study. Lancet. 2023;401(10383):1183\u201393. https:\/\/doi.org\/10.1016\/S0140-6736(23)00131-9.","journal-title":"Lancet"},{"key":"680_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fped.2013.00029","volume":"1","author":"AB Chang","year":"2013","unstructured":"Chang AB, Ooi MH, Perera D, Grimwood K. Improving the diagnosis, management, and outcomes of children with pneumonia: where are the gaps? Front Pediatr. 2013;1:29. https:\/\/doi.org\/10.3389\/fped.2013.00029.","journal-title":"Front Pediatr"},{"key":"680_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41479-016-0006-x","volume":"8","author":"K Grimwood","year":"2016","unstructured":"Grimwood K, Fong SM, Ooi MH, Nathan AM, Chang AB. Antibiotics in childhood pneumonia: how long is long enough? Pneumonia (Nathan). 2016;8:6. https:\/\/doi.org\/10.1186\/s41479-016-0006-x.","journal-title":"Pneumonia (Nathan)"},{"issue":"1","key":"680_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJMe2016328","volume":"383","author":"AB Chang","year":"2020","unstructured":"Chang AB, Grimwood K. Antibiotics for childhood pneumonia\u2014do we really know how long to treat? N Engl J Med. 2020;383(1):77\u20139. https:\/\/doi.org\/10.1056\/NEJMe2016328.","journal-title":"N Engl J Med"},{"issue":"6","key":"680_CR18","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1097\/INF.0b013e318255dc5b","volume":"31","author":"S Esposito","year":"2012","unstructured":"Esposito S, Cohen R, Domingo JD, Pecurariu OF, Greenberg D, Heininger U, et al. Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31(6):e78-85. https:\/\/doi.org\/10.1097\/INF.0b013e318255dc5b.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"680_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1155\/2015\/370240","volume":"26","author":"L Valiquette","year":"2015","unstructured":"Valiquette L, Laupland KB. Get shorty! Can J Infect Dis Med Microbiol. 2015;26(4):174\u20137. https:\/\/doi.org\/10.1155\/2015\/370240.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"680_CR20","doi-asserted-by":"publisher","unstructured":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(21)02724-0.","DOI":"10.1016\/s0140-6736(21)02724-0"},{"issue":"10442","key":"680_CR21","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1016\/s0140-6736(24)00876-6","volume":"403","author":"IN Okeke","year":"2024","unstructured":"Okeke IN, de Kraker MEA, Van Boeckel TP, Kumar CK, Schmitt H, Gales AC, et al. The scope of the antimicrobial resistance challenge. Lancet. 2024;403(10442):2426\u201338. https:\/\/doi.org\/10.1016\/s0140-6736(24)00876-6.","journal-title":"Lancet"},{"issue":"8","key":"680_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/s1473-3099(14)70780-7","volume":"14","author":"TP Van Boeckel","year":"2014","unstructured":"Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742\u201350. https:\/\/doi.org\/10.1016\/s1473-3099(14)70780-7.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"680_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cppeds.2021.101002","volume":"51","author":"E Whitney","year":"2021","unstructured":"Whitney E. Antibiotic stewardship-basic principles in urinary tract infections, community acquired pneumonia, and skin and soft tissue infections. Curr Probl Pediatr Adolesc Health Care. 2021;51(4): 101002. https:\/\/doi.org\/10.1016\/j.cppeds.2021.101002.","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"issue":"7","key":"680_CR24","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1093\/cid\/cir531","volume":"53","author":"JS Bradley","year":"2011","unstructured":"Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53(7):e25-76. https:\/\/doi.org\/10.1093\/cid\/cir531.","journal-title":"Clin Infect Dis"},{"key":"680_CR25","doi-asserted-by":"publisher","unstructured":"Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66 Suppl 2:ii1\u201323. https:\/\/doi.org\/10.1136\/thoraxjnl-2011-200598.","DOI":"10.1136\/thoraxjnl-2011-200598"},{"key":"680_CR26","unstructured":"World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries 2014. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/137319\/9789241507813_eng.pdf. Accessed 21 October 2024."},{"issue":"8","key":"680_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/pch\/20.8.441","volume":"20","author":"N Le Saux","year":"2015","unstructured":"Le Saux N, Robinson JL. Uncomplicated pneumonia in healthy Canadian children and youth: practice points for management. Paediatr Child Health. 2015;20(8):441\u201350. https:\/\/doi.org\/10.1093\/pch\/20.8.441.","journal-title":"Paediatr Child Health"},{"key":"680_CR28","doi-asserted-by":"publisher","DOI":"10.7196\/AJTCCM.2020.v26i3.104","author":"HJ Zar","year":"2020","unstructured":"Zar HJ, Moore DP, Andronikou S, Argent AC, Avenant T, Cohen C, et al. Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines. Afr J Thorac Crit Care Med. 2020. https:\/\/doi.org\/10.7196\/AJTCCM.2020.v26i3.104.","journal-title":"Afr J Thorac Crit Care Med"},{"issue":"8","key":"680_CR29","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1055\/a-1139-5132","volume":"74","author":"MA Rose","year":"2020","unstructured":"Rose MA, Barker M, Liese J, Adams O, Ankermann T, Baumann U, et al. Guidelines for the management of community acquired pneumonia in children and adolescents (Pediatric Community Acquired Pneumonia, pCAP)\u2014issued under the responsibility of the German Society for Pediatric Infectious Diseases (DGPI) and the German Society for Pediatric Pulmonology (GPP). Pneumologie. 2020;74(8):515\u201344. https:\/\/doi.org\/10.1055\/a-1139-5132.","journal-title":"Pneumologie"},{"issue":"8","key":"680_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011989","volume":"5","author":"T Lynch","year":"2010","unstructured":"Lynch T, Bialy L, Kellner JD, Osmond MH, Klassen TP, Durec T, et al. A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS ONE. 2010;5(8): e11989. https:\/\/doi.org\/10.1371\/journal.pone.0011989.","journal-title":"PLoS ONE"},{"issue":"10253","key":"680_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/s0140-6736(20)31550-6","volume":"396","author":"FM de Benedictis","year":"2020","unstructured":"de Benedictis FM, Kerem E, Chang AB, Colin AA, Zar HJ, Bush A. Complicated pneumonia in children. Lancet. 2020;396(10253):786\u201398. https:\/\/doi.org\/10.1016\/s0140-6736(20)31550-6.","journal-title":"Lancet"},{"issue":"12","key":"680_CR32","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/s2213-2600(19)30249-8","volume":"7","author":"D Goodman","year":"2019","unstructured":"Goodman D, Crocker ME, Pervaiz F, McCollum ED, Steenland K, Simkovich SM, et al. Challenges in the diagnosis of paediatric pneumonia in intervention field trials: recommendations from a pneumonia field trial working group. Lancet Respir Med. 2019;7(12):1068\u201383. https:\/\/doi.org\/10.1016\/s2213-2600(19)30249-8.","journal-title":"Lancet Respir Med"},{"key":"680_CR33","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41479-016-0012-z","volume":"8","author":"G Mackenzie","year":"2016","unstructured":"Mackenzie G. The definition and classification of pneumonia. Pneumonia (Nathan). 2016;8:14. https:\/\/doi.org\/10.1186\/s41479-016-0012-z.","journal-title":"Pneumonia (Nathan)"},{"issue":"6","key":"680_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMra011994","volume":"346","author":"K McIntosh","year":"2002","unstructured":"McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346(6):429\u201337. https:\/\/doi.org\/10.1056\/NEJMra011994.","journal-title":"N Engl J Med"},{"key":"680_CR35","doi-asserted-by":"publisher","unstructured":"The Pneumonia Etiology Research for Child Health (PERCH) study group. Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case\u2013control study. Lancet. 2019;394(10200):757-79. https:\/\/doi.org\/10.1016\/s0140-6736(19)30721-4.","DOI":"10.1016\/s0140-6736(19)30721-4"},{"issue":"Suppl 4","key":"680_CR36","doi-asserted-by":"publisher","first-page":"S363","DOI":"10.1086\/382696","volume":"38","author":"EL Nuermberger","year":"2004","unstructured":"Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis. 2004;38(Suppl 4):S363\u201371. https:\/\/doi.org\/10.1086\/382696.","journal-title":"Clin Infect Dis"},{"key":"680_CR37","doi-asserted-by":"publisher","unstructured":"The Pakistan Multicentre Amoxicillin Short-Course Therapy (MASCOT) study group. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial. Lancet. 2002;360(9336):835\u201341. https:\/\/doi.org\/10.1016\/s0140-6736(02)09994-4.","DOI":"10.1016\/s0140-6736(02)09994-4"},{"key":"680_CR38","doi-asserted-by":"publisher","unstructured":"Richards S. Oral amoxicillin for childhood pneumonia. Lancet 2003;361(9351):76 (author reply 7). https:\/\/doi.org\/10.1016\/s0140-6736(03)12133-2.","DOI":"10.1016\/s0140-6736(03)12133-2"},{"key":"680_CR39","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fped.2020.00144","volume":"8","author":"R Nenna","year":"2020","unstructured":"Nenna R, Frassanito A, Petrarca L, Di Mattia G, Midulla F. Age limit in bronchiolitis diagnosis: 6 or 12 months? Front Pediatr. 2020;8:144. https:\/\/doi.org\/10.3389\/fped.2020.00144.","journal-title":"Front Pediatr"},{"issue":"7443","key":"680_CR40","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1136\/bmj.38049.490255.DE","volume":"328","author":"G Agarwal","year":"2004","unstructured":"Agarwal G, Awasthi S, Kabra SK, Kaul A, Singhi S, Walter SD. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial. BMJ. 2004;328(7443):791. https:\/\/doi.org\/10.1136\/bmj.38049.490255.DE.","journal-title":"BMJ"},{"issue":"6","key":"680_CR41","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/tropej\/fmn050","volume":"54","author":"S Awasthi","year":"2008","unstructured":"Awasthi S, Agarwal G, Singh JV, Kabra SK, Pillai RM, Singhi S, et al. Effectiveness of 3-day amoxycillin vs. 5-day co-trimoxazole in the treatment of non-severe pneumonia in children aged 2\u201359 months of age: a multi-centric open labeled trial. J Trop Pediatr. 2008;54(6):382\u20139. https:\/\/doi.org\/10.1093\/tropej\/fmn050.","journal-title":"J Trop Pediatr"},{"issue":"5","key":"680_CR42","doi-asserted-by":"publisher","first-page":"e701","DOI":"10.1016\/S2214-109X(20)30541-6","volume":"9","author":"L Dron","year":"2021","unstructured":"Dron L, Taljaard M, Cheung YB, Grais R, Ford N, Thorlund K, et al. The role and challenges of cluster randomised trials for global health. Lancet Glob Health. 2021;9(5):e701\u201310. https:\/\/doi.org\/10.1016\/S2214-109X(20)30541-6.","journal-title":"Lancet Glob Health"},{"issue":"3","key":"680_CR43","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/cid\/ciy918","volume":"69","author":"S Sadruddin","year":"2019","unstructured":"Sadruddin S, Khan IUH, Fox MP, Bari A, Khan A, Thea DM, et al. Comparison of 3 days amoxicillin versus 5 days co-trimoxazole for treatment of fast-breathing pneumonia by community health workers in children aged 2\u201359 months in Pakistan: a cluster-randomized trial. Clin Infect Dis. 2019;69(3):397\u2013404. https:\/\/doi.org\/10.1093\/cid\/ciy918.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"680_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1912400","volume":"383","author":"A-S Ginsburg","year":"2020","unstructured":"Ginsburg A-S, Mvalo T, Nkwopara E, McCollum ED, Phiri M, Schmicker R, et al. Amoxicillin for 3 or 5 days for chest-indrawing pneumonia in Malawian children. New Engl J Med. 2020;383(1):13\u201323. https:\/\/doi.org\/10.1056\/NEJMoa1912400.","journal-title":"New Engl J Med"},{"issue":"7569","key":"680_CR45","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.38915.673322.80","volume":"333","author":"T Hazir","year":"2006","unstructured":"Hazir T, Nisar YB, Qazi SA, Khan SF, Raza M, Zameer S, et al. Chest radiography in children aged 2\u201359 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. BMJ. 2006;333(7569):629. https:\/\/doi.org\/10.1136\/bmj.38915.673322.80.","journal-title":"BMJ"},{"issue":"4","key":"680_CR46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/s1473-3099(15)70017-4","volume":"15","author":"C Rambaud-Althaus","year":"2015","unstructured":"Rambaud-Althaus C, Althaus F, Genton B, D\u2019Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis. 2015;15(4):439\u201350. https:\/\/doi.org\/10.1016\/s1473-3099(15)70017-4.","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"680_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.15172\/pneu.2014.5\/482","volume":"5","author":"KF O'Grady","year":"2014","unstructured":"O\u2019Grady KF, Torzillo PJ, Frawley K, Chang AB. The radiological diagnosis of pneumonia in children. Pneumonia (Nathan). 2014;5(Suppl 1):38\u201351. https:\/\/doi.org\/10.15172\/pneu.2014.5\/482.","journal-title":"Pneumonia (Nathan)"},{"issue":"7","key":"680_CR48","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/ppul.24339","volume":"54","author":"AC Nascimento-Carvalho","year":"2019","unstructured":"Nascimento-Carvalho AC, Ruuskanen O, Nascimento-Carvalho CM. Wheezing independently predicts viral infection in children with community-acquired pneumonia. Pediatr Pulmonol. 2019;54(7):1022\u20138. https:\/\/doi.org\/10.1002\/ppul.24339.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"680_CR49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1136\/adc.2010.189894","volume":"96","author":"MR Cardoso","year":"2011","unstructured":"Cardoso MR, Nascimento-Carvalho CM, Ferrero F, Alves FM, Cousens SN. Adding fever to WHO criteria for diagnosing pneumonia enhances the ability to identify pneumonia cases among wheezing children. Arch Dis Child. 2011;96(1):58\u201361. https:\/\/doi.org\/10.1136\/adc.2010.189894.","journal-title":"Arch Dis Child"},{"issue":"3","key":"680_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/cid\/ciq142","volume":"52","author":"T Hazir","year":"2011","unstructured":"Hazir T, Nisar YB, Abbasi S, Ashraf YP, Khurshid J, Tariq P, et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2\u201359 months: a multicenter, double-blind, randomized, placebo-controlled trial in Pakistan. Clin Infect Dis. 2011;52(3):293\u2013300. https:\/\/doi.org\/10.1093\/cid\/ciq142.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"680_CR51","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa1911998","volume":"383","author":"F Jehan","year":"2020","unstructured":"Jehan F, Nisar I, Kerai S, Balouch B, Brown N, Rahman N, et al. Randomized trial of amoxicillin for pneumonia in Pakistan. New Engl J Med. 2020;383(1):24\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1911998.","journal-title":"New Engl J Med"},{"issue":"1","key":"680_CR52","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1001\/jamapediatrics.2018.3407","volume":"173","author":"AS Ginsburg","year":"2019","unstructured":"Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Ndamala CB, Schmicker R, et al. Placebo vs amoxicillin for nonsevere fast-breathing pneumonia in Malawian children aged 2 to 59 months: a double-blind, randomized clinical noninferiority trial. JAMA Pediatr. 2019;173(1):21\u20138. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.3407.","journal-title":"JAMA Pediatr"},{"issue":"3","key":"680_CR53","doi-asserted-by":"publisher","first-page":"2002773","DOI":"10.1183\/13993003.02773-2020","volume":"56","author":"AS Ginsburg","year":"2020","unstructured":"Ginsburg AS, Klugman KP. Antibiotics for paediatric community-acquired pneumonia in resource-constrained settings. Eur Respir J. 2020;56(3):2002773. https:\/\/doi.org\/10.1183\/13993003.02773-2020.","journal-title":"Eur Respir J"},{"issue":"4","key":"680_CR54","first-page":"277","volume":"40","author":"CL Ventola","year":"2015","unstructured":"Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277\u201383.","journal-title":"P T"},{"issue":"2","key":"680_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/inf.0000000000000023","volume":"33","author":"D Greenberg","year":"2014","unstructured":"Greenberg D, Givon-Lavi N, Sadaka Y, Ben-Shimol S, Bar-Ziv J, Dagan R. Short-course antibiotic treatment for community-acquired alveolar pneumonia in ambulatory children: a double-blind, randomized, placebo-controlled trial. Pediatr Infect Dis J. 2014;33(2):136\u201342. https:\/\/doi.org\/10.1097\/inf.0000000000000023.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"680_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1001\/jamapediatrics.2020.6735","volume":"175","author":"JM Pernica","year":"2021","unstructured":"Pernica JM, Harman S, Kam AJ, Carciumaru R, Vanniyasingam T, Crawford T, et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: the SAFER randomized clinical trial. JAMA Pediatr. 2021;175(5):475\u201382. https:\/\/doi.org\/10.1001\/jamapediatrics.2020.6735.","journal-title":"JAMA Pediatr"},{"issue":"17","key":"680_CR57","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1001\/jama.2021.17843","volume":"326","author":"JA Bielicki","year":"2021","unstructured":"Bielicki JA, St\u00f6hr W, Barratt S, Dunn D, Naufal N, Roland D, et al. Effect of amoxicillin dose and treatment duration on the need for antibiotic re-treatment in children with community-acquired pneumonia: the CAP-IT randomized clinical trial. JAMA. 2021;326(17):1713\u201324. https:\/\/doi.org\/10.1001\/jama.2021.17843.","journal-title":"JAMA"},{"key":"680_CR58","doi-asserted-by":"publisher","unstructured":"Sheppard C, Fry NK, Mushtaq S, Woodford N, Reynolds R, Janes R, et al. Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014. Euro Surveill. 2016;21(50). https:\/\/doi.org\/10.2807\/1560-7917.Es.2016.21.50.30423.","DOI":"10.2807\/1560-7917.Es.2016.21.50.30423"},{"issue":"7","key":"680_CR59","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1469-0691.2004.00894.x","volume":"10","author":"P Clarke","year":"2004","unstructured":"Clarke P, Murchan S, Smyth EG, Humphreys H. Antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Ireland. Clin Microbiol Infect. 2004;10(7):657\u20139. https:\/\/doi.org\/10.1111\/j.1469-0691.2004.00894.x.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"680_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12866-024-03300-w","volume":"24","author":"JP Rodriguez-Ruiz","year":"2024","unstructured":"Rodriguez-Ruiz JP, Xavier BB, St\u00f6hr W, van Heirstraeten L, Lammens C, Finn A, et al. High-resolution genomics identifies pneumococcal diversity and persistence of vaccine types in children with community-acquired pneumonia in the UK and Ireland. BMC Microbiol. 2024;24(1):146. https:\/\/doi.org\/10.1186\/s12866-024-03300-w.","journal-title":"BMC Microbiol"},{"issue":"3","key":"680_CR61","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1001\/jamapediatrics.2021.5547","volume":"176","author":"DJ Williams","year":"2022","unstructured":"Williams DJ, Creech CB, Walter EB, Martin JM, Gerber JS, Newland JG, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. JAMA Pediatr. 2022;176(3):253\u201361. https:\/\/doi.org\/10.1001\/jamapediatrics.2021.5547.","journal-title":"JAMA Pediatr"},{"issue":"7","key":"680_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1097\/INF.0000000000003558","volume":"41","author":"GB McCallum","year":"2022","unstructured":"McCallum GB, Fong SM, Grimwood K, Nathan AM, Byrnes CA, Ooi MH, et al. Extended versus standard antibiotic course duration in children <5 years of age hospitalized with community-acquired pneumonia in high-risk settings: four-week outcomes of a multicenter, double-blind, parallel, superiority randomized controlled trial. Pediatr Infect Dis J. 2022;41(7):549\u201355. https:\/\/doi.org\/10.1097\/INF.0000000000003558.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"680_CR63","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/inf.0000000000004407","volume":"43","author":"HC Kok","year":"2024","unstructured":"Kok HC, McCallum GB, Yerkovich ST, Grimwood K, Fong SM, Nathan AM, et al. Twenty-four month outcomes of extended-versus standard-course antibiotic therapy in children hospitalized with pneumonia in high-risk settings: a randomized controlled trial. Pediatr Infect Dis J. 2024;43(9):872\u20139. https:\/\/doi.org\/10.1097\/inf.0000000000004407.","journal-title":"Pediatr Infect Dis J"},{"key":"680_CR64","doi-asserted-by":"publisher","first-page":"CD005976","DOI":"10.1002\/14651858.CD005976.pub2","volume":"2","author":"BA Haider","year":"2008","unstructured":"Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev. 2008;2:CD005976. https:\/\/doi.org\/10.1002\/14651858.CD005976.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"680_CR65","doi-asserted-by":"publisher","first-page":"e1123","DOI":"10.1093\/cid\/ciac374","volume":"76","author":"I Kuitunen","year":"2023","unstructured":"Kuitunen I, J\u00e4\u00e4skel\u00e4inen J, Korppi M, Renko M. Antibiotic treatment duration for community-acquired pneumonia in outpatient children in high-income countries\u2014a systematic review and meta-analysis. Clin Infect Dis. 2023;76(3):e1123\u20138. https:\/\/doi.org\/10.1093\/cid\/ciac374.","journal-title":"Clin Infect Dis"},{"key":"680_CR66","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2022-060097","author":"Y Gao","year":"2023","unstructured":"Gao Y, Liu M, Yang K, Zhao Y, Tian J, Pernica JM, et al. Shorter versus longer-term antibiotic treatments for community-acquired pneumonia in children: a meta-analysis. Pediatrics. 2023. https:\/\/doi.org\/10.1542\/peds.2022-060097.","journal-title":"Pediatrics"},{"issue":"12","key":"680_CR67","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1001\/jamapediatrics.2022.4123","volume":"176","author":"Q Li","year":"2022","unstructured":"Li Q, Zhou Q, Florez ID, Mathew JL, Shang L, Zhang G, et al. Short-course vs long-course antibiotic therapy for children with nonsevere community-acquired pneumonia: a systematic review and meta-analysis. JAMA Pediatr. 2022;176(12):1199\u2013207. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.4123.","journal-title":"JAMA Pediatr"},{"issue":"14","key":"680_CR68","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMc2026544","volume":"383","author":"LF Pittet","year":"2020","unstructured":"Pittet LF, Kadambari S, Abo YN. Amoxicillin course length or use in childhood pneumonia in underserved areas. N Engl J Med. 2020;383(14):1391\u20132. https:\/\/doi.org\/10.1056\/NEJMc2026544.","journal-title":"N Engl J Med"},{"key":"680_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2739","volume":"358","author":"HJ Zar","year":"2017","unstructured":"Zar HJ, Andronikou S, Nicol MP. Advances in the diagnosis of pneumonia in children. BMJ. 2017;358: j2739. https:\/\/doi.org\/10.1136\/bmj.j2739.","journal-title":"BMJ"},{"issue":"S 02","key":"680_CR70","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1055\/s-0039-1691801","volume":"36","author":"KW Yun","year":"2019","unstructured":"Yun KW, Wallihan R, Juergensen A, Mejias A, Ramilo O. Community-acquired pneumonia in children: myths and facts. Am J Perinatol. 2019;36(S 02):S54\u20137. https:\/\/doi.org\/10.1055\/s-0039-1691801.","journal-title":"Am J Perinatol"},{"issue":"8","key":"680_CR71","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.3390\/ijms20082004","volume":"20","author":"M Karakioulaki","year":"2019","unstructured":"Karakioulaki M, Stolz D. Biomarkers in pneumonia-beyond procalcitonin. Int J Mol Sci. 2019;20(8):2004. https:\/\/doi.org\/10.3390\/ijms20082004.","journal-title":"Int J Mol Sci"},{"key":"680_CR72","doi-asserted-by":"publisher","first-page":"1180746","DOI":"10.3389\/fmed.2023.1180746","volume":"10","author":"AL Jung","year":"2023","unstructured":"Jung AL, Han M, Griss K, Bertrams W, Nell C, Greulich T, et al. Novel protein biomarkers for pneumonia and acute exacerbations in COPD: a pilot study. Front Med (Lausanne). 2023;10:1180746. https:\/\/doi.org\/10.3389\/fmed.2023.1180746.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"680_CR73","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3390\/jcm8050754","volume":"8","author":"E G\u00fcell","year":"2019","unstructured":"G\u00fcell E, Mart\u00edn-Fernandez M, De la Torre MC, Palomera E, Serra M, Martinez R, et al. Impact of lymphocyte and neutrophil counts on mortality risk in severe community-acquired pneumonia with or without septic shock. J Clin Med. 2019;8(5):754. https:\/\/doi.org\/10.3390\/jcm8050754.","journal-title":"J Clin Med"},{"key":"680_CR74","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3728","author":"TA Florin","year":"2020","unstructured":"Florin TA, Ambroggio L, Brokamp C, Zhang Y, Rattan M, Crotty E, et al. Biomarkers and disease severity in children with community-acquired pneumonia. Pediatrics. 2020. https:\/\/doi.org\/10.1542\/peds.2019-3728.","journal-title":"Pediatrics"},{"issue":"1","key":"680_CR75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13052-020-0770-3","volume":"46","author":"J Thomas","year":"2020","unstructured":"Thomas J, Pociute A, Kevalas R, Malinauskas M, Jankauskaite L. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020;46(1):4. https:\/\/doi.org\/10.1186\/s13052-020-0770-3.","journal-title":"Ital J Pediatr"},{"issue":"1","key":"680_CR76","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmi.2021.09.025","volume":"28","author":"E Gentilotti","year":"2022","unstructured":"Gentilotti E, De Nardo P, Cremonini E, G\u00f3rska A, Mazzaferri F, Canziani LM, et al. Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(1):13\u201322. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.025.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"680_CR77","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1164\/rccm.201506-1100OC","volume":"193","author":"C Valim","year":"2016","unstructured":"Valim C, Ahmad R, Lanaspa M, Tan Y, Ac\u00e1cio S, Gillette MA, et al. Responses to bacteria, virus, and malaria distinguish the etiology of pediatric clinical pneumonia. Am J Respir Crit Care Med. 2016;193(4):448\u201359. https:\/\/doi.org\/10.1164\/rccm.201506-1100OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"680_CR78","doi-asserted-by":"publisher","first-page":"22554","DOI":"10.1038\/s41598-023-49734-6","volume":"13","author":"ER Ko","year":"2023","unstructured":"Ko ER, Reller ME, Tillekeratne LG, Bodinayake CK, Miller C, Burke TW, et al. Host-response transcriptional biomarkers accurately discriminate bacterial and viral infections of global relevance. Sci Rep. 2023;13(1):22554. https:\/\/doi.org\/10.1038\/s41598-023-49734-6.","journal-title":"Sci Rep"},{"issue":"9","key":"680_CR79","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835\u201345. https:\/\/doi.org\/10.1056\/NEJMoa1405870.","journal-title":"N Engl J Med"},{"issue":"4","key":"680_CR80","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1093\/cid\/cix378","volume":"65","author":"T B\u00e9net","year":"2017","unstructured":"B\u00e9net T, S\u00e1nchez Picot V, Messaoudi M, Chou M, Eap T, Wang J, et al. Microorganisms associated with pneumonia in children <5 years of age in developing and emerging countries: the GABRIEL pneumonia multicenter, prospective, case\u2013control study. Clin Infect Dis. 2017;65(4):604\u201312. https:\/\/doi.org\/10.1093\/cid\/cix378.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"680_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001444","volume":"10","author":"EB Spuesens","year":"2013","unstructured":"Spuesens EB, Fraaij PL, Visser EG, Hoogenboezem T, Hop WC, van Adrichem LN, et al. Carriage of Mycoplasma pneumoniae in the upper respiratory tract of symptomatic and asymptomatic children: an observational study. PLoS Med. 2013;10(5): e1001444. https:\/\/doi.org\/10.1371\/journal.pmed.1001444.","journal-title":"PLoS Med"},{"issue":"5","key":"680_CR82","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.anai.2013.01.022","volume":"110","author":"PR Wood","year":"2013","unstructured":"Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol. 2013;110(5):328-34.e1. https:\/\/doi.org\/10.1016\/j.anai.2013.01.022.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"680_CR83","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1542\/peds.2013-3729","volume":"133","author":"E Biondi","year":"2014","unstructured":"Biondi E, McCulloh R, Alverson B, Klein A, Dixon A, Ralston S. Treatment of mycoplasma pneumonia: a systematic review. Pediatrics. 2014;133(6):1081\u201390. https:\/\/doi.org\/10.1542\/peds.2013-3729.","journal-title":"Pediatrics"},{"issue":"1","key":"680_CR84","doi-asserted-by":"publisher","first-page":"CD004875","DOI":"10.1002\/14651858.CD004875.pub5","volume":"1","author":"SJ Gardiner","year":"2015","unstructured":"Gardiner SJ, Gavranich JB, Chang AB. Antibiotics for community-acquired lower respiratory tract infections secondary to Mycoplasma pneumoniae in children. Cochrane Database Syst Rev. 2015;1(1):CD004875. https:\/\/doi.org\/10.1002\/14651858.CD004875.pub5.","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"680_CR85","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1001\/jamapediatrics.2017.3225","volume":"171","author":"DJ Williams","year":"2017","unstructured":"Williams DJ, Edwards KM, Self WH, Zhu Y, Arnold SR, McCullers JA, et al. Effectiveness of \u03b2-lactam monotherapy vs macrolide combination therapy for children hospitalized with pneumonia. JAMA Pediatr. 2017;171(12):1184\u201391. https:\/\/doi.org\/10.1001\/jamapediatrics.2017.3225.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"680_CR86","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1186\/s13063-024-08438-6","volume":"25","author":"PM Meyer Sauteur","year":"2024","unstructured":"Meyer Sauteur PM, Seiler M, Tilen R, Osuna E, von Wantoch M, Sidorov S, et al. A randomized controlled non-inferiority trial of placebo versus macrolide antibiotics for Mycoplasma pneumoniae infection in children with community-acquired pneumonia: trial protocol for the MYTHIC Study. Trials. 2024;25(1):655. https:\/\/doi.org\/10.1186\/s13063-024-08438-6.","journal-title":"Trials"},{"issue":"7","key":"680_CR87","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.20949","volume":"5","author":"K Kim","year":"2022","unstructured":"Kim K, Jung S, Kim M, Park S, Yang HJ, Lee E. Global trends in the proportion of macrolide-resistant mycoplasma pneumoniae infections: a systematic review and meta-analysis. JAMA Netw Open. 2022;5(7): e2220949. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.20949.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"680_CR88","doi-asserted-by":"publisher","first-page":"2386636","DOI":"10.1080\/07853890.2024.2386636","volume":"56","author":"L Gao","year":"2024","unstructured":"Gao L, Sun Y. Laboratory diagnosis and treatment of Mycoplasma pneumoniae infection in children: a review. Ann Med. 2024;56(1):2386636. https:\/\/doi.org\/10.1080\/07853890.2024.2386636.","journal-title":"Ann Med"},{"issue":"3","key":"680_CR89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jiac.2018.08.018","volume":"25","author":"K Nagai","year":"2019","unstructured":"Nagai K, Kimura O, Domon H, Maekawa T, Yonezawa D, Terao Y. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017. J Infect Chemother. 2019;25(3):229\u201332. https:\/\/doi.org\/10.1016\/j.jiac.2018.08.018.","journal-title":"J Infect Chemother"},{"issue":"5","key":"680_CR90","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/qco.0000000000000960","volume":"36","author":"C Yang","year":"2023","unstructured":"Yang C, Xiang Y, Qiu S. Resistance in enteric Shigella and nontyphoidal Salmonella: emerging concepts. Curr Opin Infect Dis. 2023;36(5):360\u20135. https:\/\/doi.org\/10.1097\/qco.0000000000000960.","journal-title":"Curr Opin Infect Dis"},{"key":"680_CR91","unstructured":"World Health Organization. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. Geneva: World Health Organization 2022. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240062382. Accessed 6 December 2024."},{"issue":"3","key":"680_CR92","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00028-21","volume":"34","author":"MPE Slack","year":"2021","unstructured":"Slack MPE, Cripps AW, Grimwood K, Mackenzie GA, Ulanova M. Invasive Haemophilus influenzae infections after 3 decades of hib protein conjugate vaccine use. Clin Microbiol Rev. 2021;34(3): e0002821. https:\/\/doi.org\/10.1128\/cmr.00028-21.","journal-title":"Clin Microbiol Rev"},{"issue":"8734","key":"680_CR93","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0140-6736(91)90813-5","volume":"337","author":"TD Mastro","year":"1991","unstructured":"Mastro TD, Ghafoor A, Nomani NK, Ishaq Z, Anwar F, Granoff DM, et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet. 1991;337(8734):156\u20139. https:\/\/doi.org\/10.1016\/0140-6736(91)90813-5.","journal-title":"Lancet"},{"issue":"10","key":"680_CR94","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/00006454-199310000-00006","volume":"12","author":"TD Mastro","year":"1993","unstructured":"Mastro TD, Nomani NK, Ishaq Z, Ghafoor A, Shaukat NF, Esko E, et al. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J. 1993;12(10):824\u201330. https:\/\/doi.org\/10.1097\/00006454-199310000-00006.","journal-title":"Pediatr Infect Dis J"},{"issue":"9124","key":"680_CR95","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/s0140-6736(97)10294-x","volume":"352","author":"WL Straus","year":"1998","unstructured":"Straus WL, Qazi SA, Kundi Z, Nomani NK, Schwartz B. Antimicrobial resistance and clinical effectiveness of co-trimoxazole versus amoxycillin for pneumonia among children in Pakistan: randomised controlled trial. Pakistan co-trimoxazole study group. Lancet. 1998;352(9124):270\u20134. https:\/\/doi.org\/10.1016\/s0140-6736(97)10294-x.","journal-title":"Lancet"},{"key":"680_CR96","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-0310","author":"TA Florin","year":"2017","unstructured":"Florin TA, Ambroggio L, Brokamp C, Rattan MS, Crotty EJ, Kachelmeyer A, et al. Reliability of examination findings in suspected community-acquired pneumonia. Pediatrics. 2017. https:\/\/doi.org\/10.1542\/peds.2017-0310.","journal-title":"Pediatrics"},{"issue":"5","key":"680_CR97","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jama.2017.9039","volume":"318","author":"SN Shah","year":"2017","unstructured":"Shah SN, Bachur RG, Simel DL, Neuman MI. Does this child have pneumonia?: the rational clinical examination systematic review. JAMA. 2017;318(5):462\u201371. https:\/\/doi.org\/10.1001\/jama.2017.9039.","journal-title":"JAMA"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00680-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-024-00680-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-024-00680-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:27:53Z","timestamp":1745580473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-024-00680-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1007\/s40272-024-00680-4","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"29 December 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ABC, GBM, STY, and KG have received grants from the Australian National Health and Medical Research Council (NHMRC) and NHMRC-managed grants (Medical Research Futures Fund). ABC is also an independent data management committee member for clinical trials for Moderna (COVID-19 and Epstein-Barr virus vaccines) and of an unlicensed vaccine (GlaxoSmithKline) and monoclonal antibody (AstraZeneca) and has received fees to the institution for consulting on the study designs for Zambon and Boehringer Ingelheim, airfares for travel from the European Respiratory Society and Boehringer Ingelheim, and personal fees for being an author of two UpToDate chapters that are outside the submitted work. HCK and SMF have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Open access funding enabled and organized by CAUL and its Member Institutions. No funds, grants, or other support were received during the preparation of this manuscript. HCK is supported by the Malaysian Ministry of Health and a Charles Darwin International PhD Scholars scholarship, and ABC is supported by an NHMRC L3 fellowship (grant 2025379).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"HCK wrote the first draft of the manuscript, with revisions from KG and ABC. All authors contributed to editing the manuscript and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}